Intervention Review

Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis

  1. Marinella Clerico1,*,
  2. Fabrizio Faggiano2,
  3. Jaqueline Palace3,
  4. George PA Rice4,
  5. Mar Tintorè Subirana5,
  6. Luca Durelli1

Editorial Group: Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group

Published Online: 23 APR 2008

Assessed as up-to-date: 17 JUL 2007

DOI: 10.1002/14651858.CD005278.pub3


How to Cite

Clerico M, Faggiano F, Palace J, Rice GPA, Tintorè Subirana M, Durelli L. Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD005278. DOI: 10.1002/14651858.CD005278.pub3.

Author Information

  1. 1

    San Luigi Gonzaga University Hospital, Clinical and Biological Science Department, University of Torino, Orbassano, Torino, Italy

  2. 2

    University of Piemonte Orientale A. Avogadro, Department of Medical Sciences, Novara, Italy

  3. 3

    Radcliff Infirmary Hospital, University Department of Clinical Neurology, Oxford, UK

  4. 4

    University of Western Ontario, Clinical Neurological Sciences, London, Ontario, Canada

  5. 5

    Vall d'Hebròn University Hospital, Clinical Neuroimmunology Unit, Barcelona, Spain

*Marinella Clerico, Clinical and Biological Science Department, University of Torino, San Luigi Gonzaga University Hospital, Regione Gonzole, 10, Orbassano, Torino, 10043, Italy. marinella.clerico@unito.it.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 23 APR 2008

SEARCH

  1. Current Version

    Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis

    Marinella Clerico, Fabrizio Faggiano, Jaqueline Palace, George PA Rice, Mar Tintorè Subirana and Luca Durelli

    Version of Record online: 23 APR 2008 | DOI: 10.1002/14651858.CD005278.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis

    M Clerico, F Faggiano, J Palace, G Rice, M Tintorè and L Durelli

    Version of Record online: 18 OCT 2006 | DOI: 10.1002/14651858.CD005278.pub2

  2. Version 1

    Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis

    M Clerico, F Faggiano, J Palace, G Rice, M Tintorè and L Durelli

    Version of Record online: 20 APR 2005 | DOI: 10.1002/14651858.CD005278